Article Listing - Promotional spending on atypical antipsychotice analyzed

US FDA IMPORT DETENTIONS

13 April 1992

In the first quarter of fiscal 1992, running from October to December 31, 1991, US Food and Drug Administra-tion officials...

NEW DIAGNOSTIC FOR COLON CANCER

13 April 1992

Researchers at Johns Hopkins University Oncology Center claim to have developed the first diagnostic test capable of detecting the gene...

GERMAN BPI: MORE PATIENT CHARGES

13 April 1992

The German pharmaceutical industry association, the BPI, has called for the principle under which patients contribute to the cost of...

GROWING EC MARKET FOR HOMEOPATHY

13 April 1992

Addressing the rapid growth which the herbal medicines industry has experienced globally in recent years, international management consultant McAlpine Thorpe...

PASTEUR MERIEUX HIB VACCINE

13 April 1992

Pasteur Merieux has launched Hemophilus influenzae type B conjugate vaccine, called Act-HIB, onto the French market.

"ROLLING" NDA FOR ADRIA'S RIFABUTIN

13 April 1992

A New Drug Application for Adria Laboratories' rifabutin, a product under development as a treatment for opportunistic Mycobacterium avium complex...

IMPROVED METERED DOSE INHALER

13 April 1992

Armstrong Pharmaceuticals has signed an exclusive license agreement option for an improved metered dose inhaler from Texax-Glynn Corp. The device...

CONTINENTAL CLOSES BIOLOGICALS DIVISION SALE

13 April 1992

Continental Pharma Cryosan Inc reports that it has received a cash payment of $16.9 million on closing the sale of...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...

CERVOXAN 60mg LAUNCHED IN FRANCE

13 April 1992

Laboratoires Sobio, which is part of SmithKline Beecham, has launched a new 60mg oral formulation of Cervoxan (vinburnine) its cerebral/peripheral...

Showing 94321-94330 of 95321 articles